115 results
Page 5 of 6
6-K
EX-99.1
0ir7rcm g87
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
k066o7ne 4fb86zt364
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.2
5nm opwfbpd
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.2
3qggjvxm1jb31mzk9uk
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.3
fkaaicixcdb0
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.1
p7t5bpcoc 7qja
31 Oct 19
ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical
4:21pm
6-K
EX-99.1
e52wvh0bfirvw
6 Sep 19
ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of
8:27am
424B5
5ql53ot36y8u ci
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
3h0xfusc
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.3
2yqmprq0t1cra5
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
c8wtu m6ql9u8
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
55xbihzy
19 Jun 19
Current report (foreign)
4:30pm
6-K
EX-99.2
zk653nde6h
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
2r4exv49e0j57e
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
t1ybu76tcvl6ax
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
EX-99.2
3nee1k
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
2svuu75kfbm
9 Oct 18
Current report (foreign)
4:42pm
6-K
l2gurvilsyz9svskcmox
3 Oct 18
Current report (foreign)
9:07am
6-K
93nk07jv0lnkoedl3j
28 Sep 18
Current report (foreign)
8:40am